Old Web
English
Sign In
Acemap
>
authorDetail
>
Shiona M. Laing
Shiona M. Laing
GlaxoSmithKline
Internal medicine
Diabetes mellitus
Percutaneous coronary intervention
Myocardial infarction
Cardiology
3
Papers
26
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Adjunctive use of anticoagulants at the time of percutaneous coronary intervention in patients with an acute coronary syndrome treated with fondaparinux: a multinational retrospective review
2017
European Heart Journal - Cardiovascular Pharmacotherapy
Jill E. Abell
Shiona M. Laing
Tara C. Barker
Elliott C. Norry
Kathryn Starzyk
Shaun G. Goodman
Mikael Dellborg
P. Gabriel Steg
Robert P. Giugliano
Show All
Source
Cite
Save
Citations (2)
Phase 3 study of migalastat HCl for Fabry disease: Stage 1 results
2013
Molecular Genetics and Metabolism
Kathy Nicholls
Dominique P. Germain
Claudio Feliciani
Suma P. Shankar
Fatih Süheyl Ezgü
Salim Janmohamed
Shiona M. Laing
Rosemary Schroyer
Alexander Bragat
Sheela Sitaraman
Pol Boudes
Show All
Source
Cite
Save
Citations (4)
Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux
2010
American Heart Journal
Philippe Gabriel Steg
Shamir R. Mehta
Sanjit S. Jolly
Denis Xavier
Hans-Juergen Rupprecht
Jose Lopez-Sendon
Susan Chrolavicius
Sunil V. Rao
Christopher B. Granger
Janice Pogue
Shiona M. Laing
Salim Yusuf
Show All
Source
Cite
Save
Citations (20)
1